According to VistaGen Therapeutics 's latest financial reports the company's current earnings (TTM) are -C$52.51 M. In 2023 the company made an earning of -C$46.64 M an increase over its 2022 earnings that were of -C$87.68 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.